Literature DB >> 8905705

Antioxidant drugs block in vitro the neurotoxicity of CSF from patients with amyotrophic lateral sclerosis.

F Terro1, M Lesort, F Viader, A Ludolph, J Hugon.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease characterized by upper and lower motoneurone degeneration. Excitotoxicity and oxidative stress have been proposed as possible aetiological factors. We measured the neuronal death induced in rat cortical cell cultures by CSF taken from seven ALS patient and seven control subjects with lumbar radiculopathies. Cultures were exposed to CSF for 48 h at a dilution of 1:4. Some cultures were also exposed to antioxidant drugs, the free radical scavenger vitamin E (250 microM) and the xanthine oxidase inhibitor allopurinol (50 microM), alone or combined. The mean neuronal death rate was 31.8 +/- 3.4% in cultures exposed to ALS CSF and 10.9 +/- 1.8% in cultures exposed to control CSF. The cytotoxicity of ALS CSF was partially blocked by vitamin E (21.6 +/- 3%) or by allopurinol (18.6 +/- 2.7%). The combination of these two antioxidants reduced the toxicity from 31.8 +/- 3.4% to 10.6 +/- 1.7%. The present work suggests that neurotoxicity induced by CSF from patients with ALS indirectly involves free radicals. A combination of allopurinol and vitamin E may be useful in ALS therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905705

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  A study of glutathione S-transferase pi expression in central nervous system of subjects with amyotrophic lateral sclerosis using RNA extraction from formalin-fixed, paraffin-embedded material.

Authors:  Ewa Usarek; Beata Gajewska; Beata Kaźmierczak; Magdalena Kuźma; Dorota Dziewulska; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

Review 2.  P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis.

Authors:  Cristina Ruiz-Ruiz; Francesco Calzaferri; Antonio G García
Journal:  Front Mol Neurosci       Date:  2020-06-12       Impact factor: 5.639

Review 3.  40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?

Authors:  Koy Chong Ng Kee Kwong; Pratap K Harbham; Bhuvaneish T Selvaraj; Jenna M Gregory; Suvankar Pal; Giles E Hardingham; Siddharthan Chandran; Arpan R Mehta
Journal:  Front Mol Neurosci       Date:  2021-03-18       Impact factor: 5.639

4.  Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis.

Authors:  Anu Mary Varghese; Aparna Sharma; Poojashree Mishra; Kalyan Vijayalakshmi; Hindalahalli Chandregowda Harsha; Talakad N Sathyaprabha; Srinivas Mm Bharath; Atchayaram Nalini; Phalguni Anand Alladi; Trichur R Raju
Journal:  Clin Proteomics       Date:  2013-12-02       Impact factor: 3.988

Review 5.  Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies.

Authors:  Koy Chong Ng Kee Kwong; Jenna M Gregory; Suvankar Pal; Siddharthan Chandran; Arpan R Mehta
Journal:  Brain Commun       Date:  2020-08-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.